Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: flickerful who wrote (5036)	8/19/1998 10:05:00 PM
From: Anthony Wong	Respond to of 9523

More information about the Viagra Menu: At his Hotel de la Restauration, Galland offered a $33 three-course ''Viagra Menu'' that featured'beef piccata in Viagra sauce with fig vinegar and fine herbs,'' along with a langoustine salad and nougat ice cream with berry and ginger sauce, topped with fresh mint. Sounds delicious! Chef's Secret Ingredient Is Viagra dailynews.yahoo.com

To: flickerful who wrote (5036)	8/20/1998 6:47:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Viagra to Be Reviewed by EU Next Week; No Approval Date Set Bloomberg News August 20, 1998, 5:31 a.m. ET Viagra to Be Reviewed by EU Next Week; No Approval Date Set Brussels, Aug. 20 (Bloomberg) -- Pfizer Inc.'s Viagra will next week face scrutiny by a committee of European Union drug regulators, who'll recommend whether the European Commission should formally approve the sale of the impotence drug, an EU drug regulator said. Philippe Edouard Brunet, an official in the European Commission's pharmaceutical-products screening division, said the committee will meet ''to discuss two or three questions they still have'' about Viagra. The scrutiny of the world's best-selling impotence treatment coincides with an international conference in Amsterdam next week, attended by representatives of Pfizer, Pharmacia & Upjohn, Inc., Astra AB and other companies involved in the market for such drugs. Viagra got the backing of the European Medicines Evaluation Agency, an expert panel that advises European regulators on drug approvals, on May 29. Final approval from the commission, the EU's executive agency, usually comes two to three months after EMEA approval, Brunet said. He wouldn't confirm a Belgian press report that the drug will be approved by the end of next week. Viagra became one of the best-selling U.S. drugs within weeks of its April introduction, and black-market sales have been reported around the world. EU residents have been traveling to buy Viagra in non-EU countries such as Andorra and Switzerland. Pfizer, the second-largest U.S. drugmaker, said it could introduce Viagra in 50 countries by the end of the year if it wins EU approval. Viagra won approval from the U.S. Food and Drug Administration, the EMEA's counterpart, in March. The FDA said last month 39 men taking Viagra had died but a link to the drug hasn't been established. --Alison Jahncke in the Brussels bureau (32 2) 285 4300/ph news.com